Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 460,000
-23,000 (-4.76%)
At close: Apr 30, 2026
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 5.83 trillion as of April 30, 2026. Its market cap has increased by 99.13% in one year.
Market Cap
5.83T
Enterprise Value
6.24T
Revenue
1.55T
Ranking
n/a
PE Ratio
34.43
Stock Price
460,000.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 5.83T, an increase of 756.90%. That is a compound annual growth rate of 14.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 6.12T | 6.86% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.99T |
| Hanall Biopharma | 2.63T |
| Celltrion Pharm | 2.56T |
| Daewoong Pharmaceutical | 1.72T |
| GC Biopharma | 1.62T |
| Chong Kun Dang Pharmaceutical | 1.16T |
| DongKook Pharmaceutical | 1.14T |
| Daewoong | 942.53B |